HIGHLIGHTS
- who: Tiziana Annese from the Department of Medicine and Surgery, Libera Universitu00e0 del Mediterraneo (LUM) Giuseppe Degennaro University, Bari, Italy have published the Article: Update in TIGIT Immune-Checkpoint Role in Cancer, in the Journal: (JOURNAL) of April/30,/2022
- what: The aim of this review is to update the role of TIGIT in cancer progression, looking at last year`s studies about its pathways that are often upregulated in immune cells and possible therapeutic strategies to avoid tumor aggressiveness, drug resistance, and treatment side effects.
- how: The anti-TIGIT vibostolimab was tested . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.